Article

Evaluation of bipolar hemiarthroplasty for the treatment of steroid-induced osteonecrosis of the femoral head.

Department of Orthopaedic Surgery, School of Medicine, Kitasato University, 1 -15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa, 252-0374, Japan, .
International Orthopaedics (Impact Factor: 2.02). 07/2012; 36(10):2041-7. DOI: 10.1007/s00264-012-1612-8
Source: PubMed

ABSTRACT Bipolar hemiarthroplasty (BHA) for idiopathic osteonecrosis of the femoral head (ONFH) is performed at our institution. The purpose of this study was to evaluate the clinical and radiographic findings after BHA for the treatment of steroid -induced ONFH.
Thirty-seven hips in 27 patients were assessed (seven men, 11 hips; 20 women, 26 hips), average patient age at the time of surgery of 42.6 (range 20-83) years, with steroid-induced ONFH treated with BHA between 1995 and 2005. The mean follow-up duration was approximately ten (range five to15) years. Patients were evaluated according to the Japan Orthopaedic Association (JOA) hip score. Kaplan-Meier survivorship was calculated to examine revision arthroplasty failure rate. Radiographic analysis of loosening included radiolucent lines and osteolysis of the acetabulum or femur. Causes of loosening were analysed using multiple logistic regression.
JOA hip score increased from 53 points (preoperative) to 87 points (final follow-up). Survival rates were 96.8 % and 78.6 % at ten and 15 years, respectively. Prosthesis loosening occurred on the acetabular side in five hips (13.5 %). No femoral-component loosening was observed. BHA had poor results in patients with Association Research Circulation Osseous (ARCO) stage IV ONFH and in patients under 40 years of age.
BHA, with strict surgical indications, may be a good option for treating ONFH. Based on these results, total hip arthroplasty is recommended for patients with ARCO stage IV ONFH or for patients under 40 years of age.

0 Bookmarks
 · 
159 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: To investigate the effects of Huogu I formula on regulation of lipid metabolism in steroid-induced osteonecrosis of the femoral head (SONFH) rats and verify our hypothesis that Huogu I formula regulates lipid metabolism by down-regulating peroxisome proliferator-activated receptor gamma (PPARgamma) expression and activating Wnt signaling pathways.
    Journal of Traditional Chinese Medicine 06/2014; 34(3):342-50. · 0.59 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The purpose of this study was to predict ONFH-induced collapse based on the percentage of the proximal sclerotic rim. In total, 101 patients satisfying the inclusion criteria who received treatment at Guang'anmen Hospital were enrolled. Bilateral hip-joint computed tomography (CT) of the necrotic tissue was performed, and the largest layer within the coronal CT images was selected together with its anterior and posterior layers to calculate the proportion of the proximal sclerotic rim. The patients were divided into collapse and non-collapse groups, and the difference in the proportions of their proximal sclerotic rims was analysed. Specifically, a receiver operating characteristic (ROC) curve was created. The proportion of the proximal sclerotic rim represented by the maximal Youden's index was used as the reference value for collapse prediction, and its predictive value was assessed. The proportion in the collapse group was 13.11 ± 10.65 %, whereas the proportion in the non-collapse group was 51.91 ± 21.29 % (P < 0.01). Additionally, the proportion corresponding to the maximal Youden's index (0.902) was 29.24 %. For clinical convenience, 30 % was selected as the reference value for collapse prediction, with 97.30 % sensitivity, 87.5 % specificity, 94.01 % accuracy, a positive likelihood ratio (LR) of 7.78, and a negative LR of 0.03. Therefore, the proportion of the proximal sclerotic rim is of great significance in predicting ONFH-induced collapse, and 30 % could be used as the critical value in clinical practice. When the proportion is >30 %, the collapse risk is low, whereas at <30 %, the risk is high, and effective mechanical support should be provided.
    International Orthopaedics 11/2014; · 2.02 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background Steroid-induced osteonecrosis of the femoral head (steroid-induced ONFH) presents great challenges due to the various effects of steroids on multi-system pathways involved into osteoblast differentiation, osteoblast and osteoclast apoptosis, lipid metabolism, calcium metabolism and coagulation. As one of the most frequently used herbs in Traditional Chinese Medicine formulas that are prescribed for the regulation of bone and mineral metabolism, the therapeutic effects of Achyranthes bidentata on steroid-induced ONFH remain unclear. Thus, the aim of the current study was to verify whether Achyranthes bidentata extract (ABE) can be used to prevent steroid-induced ONFH and to investigate its underlying pharmacological mechanisms.Methods Steroid-induced ONFH rat models were established to evaluate the effects of ABE treatment on osteonecrotic changes and repair processes. Microfocal computed tomography (Micro-CT) was performed to assess the effects of ABE treatment on bone mass, microstructure, and vascularization. Then, the effects of ABE treatment on osteoclast differentiation and bone formation were also evaluated in vivo and in vitro. In addition, receptor activator of nuclear factor kappa B (RANK), RANK ligand (RANKL), and osteoprotegerin (OPG) expression in sera, femoral heads and bone marrow-derived mesenchymal stem cells (BMSCs) were detected at both protein and mRNA levels.ResultsThe ratio of empty lacuna, adipose tissue area, and adipocyte perimeter in the bone marrow were markedly lower in the ABE treatment groups than in the model group. Micro-CT evaluation indicated that ABE treatment could improve the microstructure of the trabecular bone, increase bone mineral density and promote vascularization in steroid-induced ONFH rats. Moreover, ABE treatment inhibited osteoclast differentiation and activated bone formation markers. Interestingly, OPG downregulation, RANK and RANKL upregulation, and an increased ratio of RANKL to OPG in sera and necrotic femoral head could be reversed by ABE treatment, which also effectively inhibited RANKL-induced osteoclast differentiation and regulated RANKL and OPG expression of in vitro.ConclusionABE may prevent steroid-induced ONFH and alleviate steroid-induced bone deterioration by regulating the RANKL/RANK/OPG signaling pathway.
    Journal of Translational Medicine 11/2014; 12(1):334. · 3.99 Impact Factor